European pharma leaders face a critical strategic choice: build commercial AI capabilities in-house or buy external solutions. Most organisations invest heavily in AI, yet few scale beyond pilot stage often because the decision lacks internal alignment and senior leadership buy-in. This webinar cuts through the hype to help you decide when to build, when to buy, and how to bring leadership along so the decision sticks.

You'll learn how to:

- Pinpoint the right moment to build vs. buy, using a practical decision framework tied to your organisation's maturity and commercial priorities

- Set clear internal criteria upfront, so evaluation isn't driven by vendor hype or internal politics

- Bring stakeholders across commercial, IT, compliance and data science together to secure senior leadership buy-in early, and keep momentum and funding intact

- Measure success post-decision, from ROI and time-to-value to compliance and scalability in evolving regulatory landscapes